Suzhou Teligene
Suzhou, China· Est.
Suzhou Teligene develops cell and gene therapies, including CAR-T and TCR-T technologies, for cancer immunotherapy.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Suzhou Teligene develops cell and gene therapies, including CAR-T and TCR-T technologies, for cancer immunotherapy.
OncologyCell TherapyImmunology